In myocardial fibrosis, TRPV1-mediated angiotensin II-induced cardiac fibroblast differentiation inhibits ECM deposition via a downregulation-dependent TGF-β-SMAD signaling pathway (Huang et al., 2010; Wang H.J et al., 2014). This evidence concerns the gene TRPV1 and Myocardial fibrosis.